LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 37 filers reported holding LUMOS PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,341,641 | -0.1% | 406,558 | -0.1% | 0.00% | – |
| Q2 2023 | $1,342,915 | -0.2% | 406,944 | +0.1% | 0.00% | – |
| Q1 2023 | $1,345,677 | -20.6% | 406,549 | -13.4% | 0.00% | – |
| Q4 2022 | $1,694,415 | -67.2% | 469,367 | -19.6% | 0.00% | -100.0% |
| Q3 2022 | $5,167,000 | +88.5% | 583,896 | +64.0% | 0.00% | 0.0% |
| Q2 2022 | $2,741,000 | -18.1% | 355,987 | -0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,346,000 | +35.6% | 356,008 | +0.0% | 0.00% | – |
| Q4 2021 | $2,467,000 | – | 355,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $6,714,000 | 1.63% |
| Investors Financial Group, LLC | 115,260 | $1,901,000 | 1.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,169 | $15,437,000 | 0.45% |
| NEA Management Company, LLC | 526,663 | $8,685,000 | 0.35% |
| Logos Global Management LP | 50,000 | $825,000 | 0.16% |
| Wealth Advisors of Iowa, LLC | 11,760 | $194,000 | 0.15% |
| Blackstone Inc. | 468,145 | $7,720,000 | 0.03% |
| Jefferies Group LLC | 120,651 | $1,990,000 | 0.02% |
| Texas Yale Capital Corp. | 15,000 | $247,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,043 | $199,000 | 0.00% |